DAFTAR PUSTAKA

1. Badan Penelitian dan Pengembangan Kesehatan. 2007. Laporan Hasil Riset Kesehatan

Dasar (RISKESDAS).

http://www.docstoc.com/docs/19707850/Laporan-Hasil-Riset-Kesehatan-Dasar-

%28RISKESDAS%29-Nasional-2007

2. Okie S. A New Attack on Malaria. NEJM 2008 jun 5; 358 (23): 2425-8

http://www.nejm.org/doi/full/10.1056/NEJMp0803483

3. Malaria Situation in SEAR Countries: Indonesia

http://www.searo.who.int/en/Section10/Section21/Section340_4022.htm

4. Harijanto PN. Malaria. 2007. Di dalam: Sudoyo AW, Setiyohadi B, Alwi I, K MS,

Setiadi S, Editor. Buku Ajar Ilmu Penyakit Dalam. Ed ke-4. Jakarta: Fakultas Kedokteran

Universitas Indonesia. Hlm 1732-48.

5. Sutanto, Inge, Ismid, Is Suhariah, dkk. 2008Buku Ajar Parasitologi Kedokteran. Ed ke-4.

Jakarta: Balai Penerbit FKUI. Hlm 195-141.

6. White NJ, Breman JG. 2005. Malaria and Babesiosis: Disease Caused By Red Blood Cell

Parasites. Di dalam: Kasper DL, Braunwald D, Fauci AS, Hauser SL, Longo DL,

Jameson JL, editor. Harrison’s Principles of Internal Medicine. 16th Ed. United States of

America: McGraw-Hill Companies, Inc. Hlm 1218-33.

7. History, Aetiology, Pathophysiology, Clinical Features, Diagnosis, Treatment,

Complications and Control of Malaria.

http://www.malariasite.com/malaria/LifeCycle.htm

8. Abbas, A.K., Lichtman, A.H., and Pillai, S. 2007. Cellular and Molecular Immunology.

6th Edition. Saunders Elsevier, Philadelphia.

9. Wanenoor. 2011. Respon imun terhadap infeksi parasit.

http://id.shvoong.com/medicine-and-health/imuunology/2105950-respon-imun-terhadap-

infeksi-parasit/#ixzz1R2v6POAU

10.Ambarita, Lasbudi P. 2009. Malaria: Vaksinasi sampai Resistensi .

http://hnz11.wordpress.com/2009/05/22/

42

43

11. Haas M, Fulling S. 2006. Plasmodium falciparum Apical Membrane Antigen 1

(AMA1).

http://biology.kenyon.edu/BMB/Chime2/2006/AMA1/index.htm#STRUCTURE

12. Ostrovsky Gene. 2010. New Malaria Vaccine Passes Initial Clinical Trial.

http://medgadget.com/2010/02/new_malaria_vaccine_passes_initial_clinical_trial.html

13. Hu J, Chen Z, Gu J, Wan M, Shen Q, Kieny MP, et al. 2008. Safety and Immunogenicity

of a Malaria Vaccine, Plasmodium falciparum AMA-1/MSP-1 Chimeric Protein

Formulated in Montanide ISA 720 in Healthy Adults. PLoS ONE 3(4): e1952.

http://www.plosone.org/article/info:doi/10.1371/journal.pone.0001952

14. Ouattara A, Mu J, Harrison ST, Saye R, Sagara I, Dicko A, et al. 2010. Lack of allele-

specific efficacy of a bivalent AMA1 malaria vaccine. Malaria Journal 2010, 9:175

http://www.malariajournal.com/content/9/1/175

15. Cech PG, Aebi T, Abdallah MS, Mpina M, Machunda EB, Westerfeld N, et al. 2011.

Virosome-Formulated Plasmodium falciparum AMA-1 & CSP Derived Peptides as

Malaria Vaccine: Randomized Phase 1b Trial in Semi-Immune Adults & Children. PLoS

ONE 6(7): e22273

http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0022273

16. Dicko A, Diemert DJ, Sagara I, Sogoba M, Niambele MB, Assadou MH, et al. 2007.

Impact of a Plasmodium falciparum AMA1 Vaccine on Antibody Responses in Adult

Malians. PLoS ONE (10): e1045

http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0001045

17. Dicko A, Sagara I, Ellis RD, Miura K, Guindo O, Kamate B, et al. 2008. Phase 1 Study

of a Combination AMA1 Blood Stage Malaria Vaccine in Malian Children. PLoS ONE

3(2): e1563

http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0001563

18. Studi di Mali, Afrika Barat menunjukkan kemungkinan vaksin malaria resisten. 2009.

http://www.news-medical.net/news/20091015/44/Indonesian.aspx

19. Zhu Daming, McClellan H, Wu Y. 2011. Long Term Stability Of A Recombinant

Plasmodium Falciparum AMA1 Malaria Vaccine Adjuvanted With Montanide® ISA720

and Stabilized With Glycine. Vaccine 29(20), 9 May 2011, Pages 3640-3645

43

http://www.malariaworld.org/article/long-term-stability-recombinant-plasmodium-

falciparum-ama1-malaria-vaccine-adjuvanted-montan